
--- Page 1 ---
IcD-0=3 8ite: breaot Nos c509 'fS/s Hosfu h Surg Path CLINICAL HISTORY: Right breast FNA negative. 2 x 1.5 cm tumor. Oriented by Dr. grossly. GROSS EXAMINATION: A. *Right breast biopsy", in formalin. The specimen consists of a 6.0 x 3.8 x 2.8 cm sample of firm, yellow-white, fibroadipose tissue that is received previously incised. The specimen was oriented grossly by Dr. , and the lateral operative margin inked in blue, medial operative margin inked in black, and the anterior operative margin inked in red. The specimen is sectioned superiorly to inferiorly revealing a firm, white scuirrious uniform lesion with irregular borders extending up to 2 cm in greatest dimension. The lesion abuts the medial and inferior operative margins. The specimen is submitted in toto in Blocks Al-Al3 from inferior to superior and anterior to posterior. Also received is a sample of firm, yellow-white fibroadipose tissue measuring 4.3 x 4.0 x 1.3 cm in size. The sample is oriented by Dr. and the new. surgical margin is inked in blue and the old surgical margin is inked in black. The new surgical margin represents the true margins. Serial sectioning reveals a firm, white, infiltrative lesion extending through much of the specimen and abutting the blue inked surgical margin. Submitted in toto in Blocks Al4-A20. Samples of the lesion were obtained for Er/pr studies.. FOrM Dr. DIAGNOSIS: A. "RIGHT BREAST BIOPSY" (EXCISIONAL BIOPSY): per tss patn userepancy INFILTRATING CARCINOMA PRESENT, HISTOLOGIC TYPE, DUCTAL. Fom, TCGAtumor is cribriFyrm N.S.A.B.P. HISTOLOGIC GRADE, 2 OF 3. N.S.A.B.P. NUCLEAR GRADE, 2 OF 3. UUID: 84A8BA4A-35F0-46C4-BDB0-64C033AFD1A8 GROSS TUMOR SIZE, 2 CM. TCGA-B6-A0X0-01A-PR Redacted SIZE OF INVASIVE COMPONENT, 2 CM. DUCTAL IN-SITU CARCINOMA, EXTENSIVE. MULTIFOCAL TUMOR, NO. TYPE OF IN SITU CARCINOMA, NON-COMEDO SUBTYPES. SIZE OF IN SITU CARCINOMA, 2 CM. STATUS OF NON-NEOPLASTIC BREAST TISSUE, APOCRINE METAPLASIA AND DUCTS ECTASIA. LYMPHATIC/VASCULAR INVASION, NOT PRESENT. SURGICAL MARGIN STATUS, NEGATIVE. MICROCALCIFICATIONS NOT PRESENT. ESTROGEN/PROGESTERONE AND CELL CYCLE ANALYSIS PENDING, YES. METHODOLOGY, FRESH TISSUE. SEE NOTE. RESULTS WILL BE ISSUED IN AN ADDENDUM. NOre: The original biopsy specimen shows carcinoma in situ to both lateral and medial margins. The reexcision specimen shows operative margins to be free of malignancy. This specimen shows a single small. focus of residual invasive carcinoma, infiltrating ductal type, N.s.A.B.p. histologic grade 2, nuclear grade 2, and residual intraductal carcinoma of non-comedo type. Breast tissue away from the carcinoma in this specimen shows blunt duct adenosis and a small radial scar. 1 of 2

--- Page 2 ---
Verified by:. Pager# Date Signed: ADDENDUM 1: Tissue was sent to the for assay of the Estrogen and Progesterone receptors. an estimated fmol valve of 166. The Progesterone receptor was judged as positive with an estimated fmol valve of 1l. Please report to more complete details. : for Verified by:. Pager Date Signed:. 2 of 2

--- Page 3 ---
TCGA Pathologic Diagnosis Discrepancy Form V4.00 Instructions: The TcGA Pathologic Diagnosis Discrepancy Form should be completed when the pathologic diagnosis : documented on the initial pathology report for a case submitted for TcGA is inconsistent with the diagnosis provided on the Case Quality Control Form completed for the submitted case.. Tissue Source Site (Tss): .-.. TSS Identifiet. .  TSS Unique Patlent Identifier: Completed By (interviewer Name on Completed Date: Diagnosis Information.. Data Element Entry Alternatives Working Instructions Provide the diagnosis/ histologic subtype(s) documented on Pathologic Diagnosis the initial pathology report for thls case.lf the histology for  Provided on Initial Pathology Report Qresert, DuctoI Histologic features of Cibriform Provide the histologic features selected on the TCGA Case Quality Control Form completed for this case.. the sample provided for TCGA, as reflected on the CQCF. Discrepancy between Pathology Report and Case Quality Control Form Provide the reason for Provide a reason describing why the diagnosis on the inltial the discrepancy S0mple Subm#ed pathology report for this case isnot consistent with the between the pathology djagnosis selected on the TCGA Case Quality Control Form. report and the TCGA reviewed smd Case Quality Control Form. Oqreed tnat itis Cribri Form.  Name of Tss Reviewing Provide the name of the pathologist who reviewed this case. Pathologist or. forTCGA. Biorepository Director I acknowledge that the above information provided by my institution is true and correct and has been quallty controlled. TSS Reviewing Pathologist or Biorepository Director Date I acknowledgs that the above Information provided by my instituton is true and correct and has been quality controlled. The Attending Pathotogist or the uxartment Chairman has been Informed or is aware of the above discrepancy in dlagnoses. Principal Investigator Signature Date